ENvue Medical Inc
FEED
6 hedge funds and large institutions have $539K invested in ENvue Medical Inc in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
62% less capital invested
Capital invested by funds: $1.43M → $539K (-$889K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$149K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$71.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$26.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$243K |
FEED Hedge Fund Activity: Q3 2020 in Review
6 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q3 2020, worth a combined $539K — down 62% from $1.43M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FEED positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Kennedy Capital Management, adding an estimated $149K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $243K sold.
- 6 institutional investors held ENvue Medical Inc (FEED) as of Q3 2020, up from 3 in Q2 2020.
- Funds reported $539K of ENvue Medical Inc stock for Q3 2020, down 62% quarter-over-quarter.
- 4 funds opened new ENvue Medical Inc positions in Q3 2020 and 1 closed out, a net change of +3 holders.
- The largest ENvue Medical Inc buyer in Q3 2020 was Kennedy Capital Management, an estimated $149K added.
- The largest ENvue Medical Inc seller in Q3 2020 was Worth Venture Partners, an estimated $243K sold.
Based on aggregated 13F filings for Q3 2020.